{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:16:07Z","timestamp":1792631767253,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamapsychiatry.2018.0568","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T16:31:38Z","timestamp":1524673898000},"page":"733","source":"Crossref","is-referenced-by-count":32,"title":["Association of Substance Use Disorders With Conversion From Schizotypal Disorder to Schizophrenia"],"prefix":"10.1001","volume":"75","author":[{"given":"Carsten","family":"Hjorth\u00f8j","sequence":"first","affiliation":[{"name":"Copenhagen University Hospital, Mental Health Center Copenhagen, Hellerup, Denmark"},{"name":"The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Copenhagen and Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Albert","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Mental Health Center Copenhagen, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Nordentoft","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital, Mental Health Center Copenhagen, Hellerup, Denmark"},{"name":"The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Copenhagen and Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"yoi180019r1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2006.01.002","article-title":"Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial: a randomized clinical trial of integrated treatment and standard treatment.","volume":"83","author":"Nordentoft","year":"2006","journal-title":"Schizophr Res"},{"issue":"3","key":"yoi180019r2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/wps.2011.10.issue-3","article-title":"Self-experience in the early phases of schizophrenia: 5-year follow-up of the Copenhagen Prodromal Study.","volume":"10","author":"Parnas","year":"2011","journal-title":"World Psychiatry"},{"key":"yoi180019r3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.schres.2016.10.013","article-title":"Course of illness in a sample of patients diagnosed with a schizotypal disorder and treated in a specialized early intervention setting: findings from the 3.5 year follow-up of the OPUS II study.","volume":"182","author":"Albert","year":"2017","journal-title":"Schizophr Res"},{"issue":"1","key":"yoi180019r4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/schbul\/21.1.47","article-title":"Schizotypal personality disorder in parents and the risk for schizophrenia in siblings.","volume":"21","author":"Kendler","year":"1995","journal-title":"Schizophr Bull"},{"issue":"7","key":"yoi180019r5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/archpsyc.1990.01810190034005","article-title":"Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients.","volume":"47","author":"Siever","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi180019r6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00127-015-1104-4","article-title":"Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study.","volume":"51","author":"Toftdahl","year":"2016","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1-3","key":"yoi180019r7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.schres.2013.10.018","article-title":"Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"151","author":"Davis","year":"2013","journal-title":"Schizophr Res"},{"issue":"9584","key":"yoi180019r8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"yoi180019r9","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1017\/S0033291717000162","article-title":"Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.","volume":"47","author":"Nielsen","year":"2017","journal-title":"Psychol Med"},{"issue":"7","key":"yoi180019r10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System.","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"yoi180019r11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1403494810395825","article-title":"The Danish Psychiatric Central Research Register.","volume":"39","author":"Mors","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"yoi180019r12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register.","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"yoi180019r13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry.","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"6","key":"yoi180019r15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1192\/bjp.bp.109.064220","article-title":"High-potency cannabis and the risk of psychosis.","volume":"195","author":"Di Forti","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"3","key":"yoi180019r16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.","volume":"2","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"yoi180019r17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis: a systematic meta-analysis.","volume":"68","author":"Large","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"yoi180019r18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/schbul\/sbs188","article-title":"Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend.","volume":"39","author":"Stefanis","year":"2013","journal-title":"Schizophr Bull"},{"issue":"5","key":"yoi180019r19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/add.2005.100.issue-5","article-title":"Cannabis use predicts future psychotic symptoms, and vice versa.","volume":"100","author":"Ferdinand","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"yoi180019r20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","article-title":"Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.","volume":"65","author":"Cannon","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"yoi180019r21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2009.206","article-title":"Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European Prediction of Psychosis Study.","volume":"67","author":"Ruhrmann","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi180019r22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/schbul\/sbt114","article-title":"Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies.","volume":"40","author":"Rasic","year":"2014","journal-title":"Schizophr Bull"},{"issue":"3","key":"yoi180019r23","first-page":"287","article-title":"Substance abuse and psychosis: the strange case of opioids.","volume":"18","author":"Maremmani","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"yoi180019r24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S2215-0366(15)00152-2","article-title":"Does tobacco use cause psychosis? systematic review and meta-analysis.","volume":"2","author":"Gurillo","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"yoi180019r25","article-title":"Tobacco smoking and risk of first episode psychosis: a case-control study in Sao Paulo, Brazil.","volume":"6","author":"Menezes","year":"2016","journal-title":"npj Schizophr"},{"issue":"10","key":"yoi180019r26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.","volume":"59","author":"McGorry","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"yoi180019r27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4088\/JCP.12m07785","article-title":"Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.","volume":"74","author":"McGorry","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"yoi180019r28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1176\/ajp.2006.163.5.790","article-title":"Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.","volume":"163","author":"McGlashan","year":"2006","journal-title":"Am J Psychiatry"},{"key":"yoi180019r14","unstructured":"Styrelsen for Arbejdsmarked og Rekruttering. The DREAM database. http:\/\/www.dst.dk\/-\/media\/Kontorer\/13-Forskning-og-Metode\/DREAM-koder-version-39.pdf?la=da. March 20, 2017. Accessed April 28, 2017."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2678577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T18:54:32Z","timestamp":1530644072000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.0568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.0568","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}